Basic Stugeron Information

• INN (International Nonproprietary Name): Cinnarizine
• Brand Names Available In United States: Not specified
• ATC Code: N07CA02 — Nervous system drugs; other nervous system drugs; calcium channel blockers for vestibular disorders
• Forms & Dosages: Oral tablet 25 mg most common; extended‑release tablets (rare, some markets); syrup/suspension in select regions
• Manufacturers In United States: Not specified
• Registration Status In United States: Not specified
• OTC / Rx Classification: Mostly OTC in EU & UK for motion sickness; may require prescription in some countries or for specific indications

Everyday Use & Best Practices

Morning Vs Evening Dosing

Worried about whether to take Stugeron in the morning or at night when you travel?

For motion sickness, take one 25 mg tablet about two hours before travel and repeat every eight hours as needed.

For ongoing vertigo or circulatory indications, the common adult regimen per product information is 25 mg three times daily (total 75 mg/day).

If you feel unusually drowsy after a dose, avoid driving or operating heavy machinery until you know how it affects you.

Consider taking the largest or most sedating dose at home or in the evening when practical.

Elderly adults may need lower doses because of increased risk of sedation and confusion; discuss adjustments with a clinician.

Taking With Or Without Meals

Are you prone to stomach upset when taking meds?

Cinnarizine can be taken with or without food.

Taking it with food may reduce stomach upset and can help if you are already nauseated.

For motion sickness, take the tablet before a meal or a light snack so the medicine is not on an empty stomach.

For chronic use, align doses with regular meals (breakfast, lunch, dinner) to improve adherence.

• Pre-Travel Checklist: Pack tablets, plan first dose two hours before departure, bring a small snack, avoid alcohol before travel, know how drowsy you get.

Use	Dosing
Motion Sickness	25 mg, 2 hours before travel; repeat every 8 hours as needed
Vertigo / Vestibular Disorder	25 mg, three times daily (total 75 mg/day)
Cerebral/Peripheral Circulatory Disorders	25 mg, two to three times daily depending on response

Common comparable medicines to discuss with your clinician include meclizine and dimenhydrinate for motion sickness and vertigo medicine choices like betahistine for certain vestibular disorders.

Safety Priorities

Who Should Avoid It

Do you have conditions that make cinnarizine unsafe?

Absolute contraindications from the product information include known allergy to cinnarizine or any excipients.

Do not use if you have disorders of porphyrin metabolism (porphyria).

Avoid in severe hepatic impairment.

Pregnancy and breastfeeding are listed as situations to avoid cinnarizine unless absolutely necessary.

People with Parkinson’s disease should avoid cinnarizine or use it only under specialist supervision because it may worsen extrapyramidal symptoms.

If you have significant liver or kidney impairment, consult your clinician for possible dose adjustment.

Activities To Limit

Worried about staying safe while taking Stugeron?

Cinnarizine commonly causes drowsiness and may impair alertness.

Limit driving, operating heavy machinery, or performing tasks requiring rapid decision-making until you know how it affects you.

Avoid alcohol and other central nervous system depressants while using cinnarizine.

Be cautious when combining with sedating antihistamines such as doxylamine or with opioids and benzodiazepines.

• Do Not Do: Drive or operate heavy machinery after dosing until effects are known.
• Do Not Do: Mix alcohol with cinnarizine.
• Do Not Do: Combine without clinician input with antipsychotics if you have Parkinsonian symptoms.

Age Group	Primary Risk	Recommended Action
Children (5–12)	Less data; dosing adjustment required	Use pediatric dose; monitor closely
Adults (18–64)	Drowsiness, anticholinergic effects	Follow standard dosing; avoid alcohol
Elderly (65+)	Higher risk of sedation, confusion, extrapyramidal symptoms	Consider lower dose and frequent review

Dosage & Adjustments

General Regimen

Need a clear dosing plan for Stugeron?

Standard adult dosing from product data is:

Motion sickness — 25 mg taken about two hours before travel, with repeats every eight hours if needed.

Vertigo/vestibular disorder — 25 mg three times daily (total 75 mg/day).

For circulatory or chronic indications, clinicians often prescribe 25 mg two to three times daily depending on clinical response.

Extended‑release and syrup forms exist in selected markets but are less common than 25 mg tablets.

Special Cases

Concerned about children, elderly patients, or liver problems?

Children: Not recommended under age five.

Ages five to twelve: 12.5 mg two to three times daily per product information.

Elderly: Reduce dose and monitor for sedation, confusion, or extrapyramidal symptoms.

Hepatic impairment: Use with caution because primary hepatic metabolism involves CYP2D6; dose reduction may be needed.

Missed dose: Take when remembered unless it is close to the next scheduled dose; do not double up.

Patient Group	Typical Dose
Adult Motion Sickness	25 mg, 2 hours before travel; repeat q8h as needed
Adult Vertigo	25 mg, three times daily (75 mg/day)
Children 5–12	12.5 mg, two to three times daily
Children <5	Not recommended

• Dose Adjustment Checklist: Lower dose for elderly; consult if liver disease; pediatric dosing only as specified; do not double missed doses.

User Testimonials

Positive Reports

Wondering whether people actually get relief from Stugeron?

Many users report fast relief from motion-induced nausea when taking 25 mg prior to travel.

Reports often describe reduced spinning sensation and improved tolerance for long drives or boat trips within hours.

For chronic vertigo, patients commonly note fewer dizzy spells and improved balance after days to weeks of consistent therapy.

Real-world feedback frequently highlights the convenience and affordability of 25 mg tablets under brand names like Stugeron in markets where available.

Common Challenges

What side effects do people mention most often?

Frequent complaints include daytime drowsiness, dry mouth, and occasional weight gain with long-term use.

Some users describe mild cognitive slowing or restlessness; elderly patients sometimes report confusion.

A small minority discontinue because of extrapyramidal symptoms such as rigidity or tremor — more likely after prolonged use.

• Pros: Effective for motion sickness, affordable where available, simple dosing.
• Cons: Sedation risk, possible long‑term weight gain, rare movement disorders with extended therapy.

Suggested talking points for physician visits: discuss sedation, review alternatives like meclizine or dimenhydrinate, and plan monitoring for extrapyramidal signs if treatment will be long-term.

Buying Guide

Pharmacy Sources

Trying to figure out where to buy Stugeron from the United States?

Stugeron (cinnarizine 25 mg) is commonly available OTC in many EU countries, the UK, and Canada, with packaging that varies by market.

In the United States, cinnarizine is not commonly registered and access may require a prescription, special importation, or purchase through international or online pharmacies.

Always confirm local regulations and verify pharmacy licensure before ordering online.

In our online pharmacy, Stugeron is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

How do prices compare across suppliers?

Prices vary by country, brand, and pack size.

Generics from suppliers like STADA, Hasco, Biogaran, and LEK typically cost less than originator brands.

When comparing cost, check milligrams per tablet, pack size, and shipping or import fees.

Beware unusually cheap sources; prefer licensed pharmacies and verify batch and expiry details before purchase.

Region	Availability	Typical Pack
Europe (EU/UK)	Common (OTC in many countries)	Blister packs 10–50; boxes of 100
Canada	Available; status varies by province	25 mg tablets, often non-Rx
United States	Uncommon / Not widely registered	May require prescription or import

What’s Inside & How It Works

Ingredients Overview

Curious what’s in a Stugeron tablet?

The active ingredient is cinnarizine (INN), most commonly supplied as 25 mg oral tablets.

Extended‑release tablets and syrup formulations exist in select regions.

Excipients differ by manufacturer, so check product labeling for potential allergens.

Manufacturers include Janssen (original), STADA, Hasco, Biogaran, LEK, and Gedeon Richter among others.

Mechanism Basics

How does cinnarizine reduce motion sickness and vertigo?

Cinnarizine is an antihistaminic and a calcium channel blocker categorized under ATC N07CA02.

It acts on the vestibular system to reduce motion-provoked signaling and on cerebral and peripheral microcirculation to address circulatory disturbances.

The combination of antihistamine and vestibular‑stabilizing effects explains its benefit in motion sickness and vertigo.

Its central nervous system depressant properties explain the common sedation side effect.

Action	Symptom Relief	Common Side Effects
Antihistamine	Reduces vestibular sensitivity	Drowsiness, dry mouth
Calcium Channel Blockade	Improves microcirculation in brain and inner ear	Fatigue, mild GI upset

Main Indications

Approved Uses

What conditions is Stugeron approved to treat?

Per product information, approved indications include prevention and treatment of motion sickness and management of vestibular disorders and vertigo.

It is also indicated in some markets for certain cerebral and peripheral circulatory disorders where microcirculatory improvement is intended.

Off-Label Uses

Can clinicians prescribe cinnarizine for other dizziness problems?

Clinicians occasionally use cinnarizine off-label for prolonged dizziness syndromes or as adjunct therapy for certain balance disorders.

Alternatives commonly considered include betahistine, meclizine, and dimenhydrinate; choice depends on side-effect profile and comorbidities.

• Approved Uses: Motion sickness, vertigo/vestibular disorders, selected circulatory indications.
• Off-Label: Prolonged dizziness syndromes, adjunctive balance disorder therapy.

Interaction Warnings

Food Interactions

Will food change how Stugeron works?

No major food interactions are documented in the product data.

Taking cinnarizine with food may reduce stomach upset.

Avoid alcohol while taking cinnarizine because it adds to sedation and increases risk when performing tasks like driving.

Drug Conflicts

Which medicines should you mention to your provider before using Stugeron?

Cinnarizine can interact additively with other CNS depressants such as opioids, benzodiazepines, and sedating antihistamines like doxylamine, increasing sedation.

It may worsen extrapyramidal symptoms if combined with antipsychotics or other dopamine antagonists.

Because hepatic metabolism via CYP2D6 is involved, caution is advised with strong CYP2D6 modulators; consult your prescriber for polypharmacy reviews.

• Tell Your Provider About: Opioids, benzodiazepines, sedating antihistamines (for example doxylamine), antipsychotics, strong CYP2D6 inhibitors or inducers.

Drug Class	Risk With Cinnarizine	Recommendation
Opioids / Benzodiazepines	Increased sedation	Avoid combination or adjust clinically
Sedating Antihistamines (e.g., doxylamine)	Increased drowsiness	Use caution
Antipsychotics	Worsening extrapyramidal symptoms	Specialist supervision required

Latest Evidence & Insights

Summary Of Recent Findings

How does cinnarizine perform compared with other motion sickness meds?

Clinical literature positions cinnarizine as an effective vestibular suppressant and motion sickness agent.

It is often compared favorably for efficacy but tends to carry a greater sedation risk than some “less drowsy” agents.

Evidence supports short-term use for travel and longer courses for certain vestibular disorders with monitoring for side effects.

Practical Takeaway

Trying to pick the right medicine for travel or chronic dizziness?

If minimal drowsiness is a priority, consider alternatives such as meclizine or certain dimenhydrinate preparations marketed as less drowsy.

For stronger vestibular control where sedation is tolerated, cinnarizine remains a practical choice.

Always reassess benefit versus adverse effects after several weeks in chronic use and discuss switches to alternatives when needed.

• Evidence Levels: Short-term randomized trials for motion sickness; real-world and longer-term observational data for chronic vestibular use.
• Clinician Prompts: Evaluate sedation impact, review alternatives, monitor for movement disorders during prolonged therapy.

Alternative Choices

Comparable Medicines

Not sure which motion sickness medicine to try instead of Stugeron?

Common alternatives include dimenhydrinate (Dramamine), meclizine (Bonine, Antivert), promethazine (Phenergan), and betahistine (Serc) for certain vestibular disorders.

Each medicine has a different sedative or anticholinergic profile and different regulatory availability by country.

Choosing Based On Lifestyle

Do you need to stay alert after dosing?

If you must drive or remain alert, favor less-drowsy options such as meclizine or consider dosing strategies and timing to minimize impairment.

For severe nausea where maximum antiemetic effect is needed, promethazine may be effective but is more sedating.

Betahistine is often used for Ménière’s disease and works differently from vestibular suppressants.

Medicine	Typical Efficacy	Sedation	Typical Dose
Cinnarizine (Stugeron)	Good for motion sickness and vertigo	Moderate to high	25 mg tablets; see indications
Meclizine (Bonine)	Effective for motion sickness and vertigo	Less drowsy option	25–50 mg once daily (varies)
Dimenhydrinate (Dramamine)	Effective for motion sickness	Moderate	50–100 mg pre-travel, repeat as needed (varies)
Promethazine (Phenergan)	Strong antiemetic	High	25 mg (varies by route and use)

Regulation Snapshot

Where It’s Available

Can travelers buy Stugeron in their destination country?

Stugeron/cinnarizine 25 mg is widely available OTC in many European countries, the UK, and in Canada depending on province.

It may be unregistered or uncommon in Australia and the United States; check local drug registries and pharmacy policies before travel.

OTC Vs Rx Considerations

Does it require a prescription everywhere?

Where offered OTC, typical use is for motion sickness and short-term needs.

For chronic vestibular disorders clinicians often prescribe and monitor therapy.

Always verify local labeling for contraindications such as pregnancy and porphyria and follow pack-specific storage instructions.

Country/Region	Availability
EU / UK	Mostly OTC for motion sickness
Canada	Available; provincial variation
Australia	Not registered on public formulary
United States	Uncommon; may require prescription or import

FAQ Section

Quick Answers (Common Questions)

Will Stugeron make me sleepy?

Yes, drowsiness is a common side effect; avoid driving until you know how it affects you.

Can I take Stugeron while pregnant?

Product information advises avoiding cinnarizine during pregnancy and breastfeeding unless absolutely necessary.

How fast does it work for motion sickness?

It is typically taken about two hours before travel; onset varies but treatment is usually helpful within hours.

When To Call A Doctor

When should you seek medical attention while taking cinnarizine?

Seek immediate care for signs of severe allergic reaction, persistent confusion, seizures, or new movement disorders such as tremor or rigidity.

Also consult if drowsiness or cognitive effects interfere with daily life or for dose adjustments in elderly patients or those with liver disease.

• When To Call: Severe rash, breathing difficulty, persistent confusion, seizures, new tremors, or significant sedation affecting function.

Guidelines For Proper Use

Practical Daily Checklist

Want a simple checklist to keep your Stugeron use safe and effective?

Store at room temperature in a cool, dry place away from sunlight and out of reach of children.

For travel, pack the exact number of tablets needed, bring a copy of your prescription if applicable, and print product information if crossing borders.

Follow dosing: 25 mg about two hours before travel and repeat every eight hours for motion sickness; chronic regimens usually 25 mg three times daily.

Monitoring And Follow-Up

What monitoring is needed for long-term use?

If using cinnarizine long-term, schedule periodic reviews for effectiveness and side effects such as sedation, weight gain, and extrapyramidal signs.

Elderly patients require closer monitoring and likely dose reduction.

For suspected overdose — signs include excess drowsiness, confusion, or seizures — seek emergency care immediately.

Monitoring Item	Frequency / Action
Effectiveness (reduction in dizziness)	Review after several weeks
Sedation / Cognitive Effects	Monitor continuously; adjust dose if problematic
Movement Disorders	Assess at each visit for prolonged therapy

Delivery Across United States

City	Region	Delivery time
New York	New York	5-7 days
Los Angeles	California	5-7 days
Chicago	Illinois	5-7 days
Houston	Texas	5-7 days
Phoenix	Arizona	5-7 days
Philadelphia	Pennsylvania	5-7 days
San Antonio	Texas	5-7 days
San Diego	California	5-7 days
Dallas	Texas	5-7 days
San Jose	California	5-7 days
Austin	Texas	5-7 days
Jacksonville	Florida	5-9 days
Columbus	Ohio	5-9 days